About USTAR
Hangzhou Ustar Biotechnologies Co., Ltd. (USTAR) is a global diagnostics company, founded in 2005, dedicated to the research, development, production, and commercialisation of innovative point-of-care molecular diagnostic (POCT) technologies. USTAR focuses on enabling rapid, accurate, and accessible molecular testing, supporting healthcare providers across clinical, laboratory, and decentralised environments.
USTAR has developed a comprehensive molecular POCT solution spanning clinical diagnostics, disease prevention and control, and biosecurity applications, including agriculture and livestock quarantine. The company has actively contributed to major national scientific programs in infectious disease control.
Their molecular POCT solution, MultNAT® is an advanced diagnostic testing platform designed to deliver multiplex, and quantitative nucleic acid testing in both laboratory and near-patient settings. Built on USTAR's innovative isothermal amplification technology, MultNAT® brings laboratory-quality molecular diagnostics to the point of care, enabling faster and more accessible infectious disease testing.
With a growing and resilient test menu, MultNAT® supports a wide range of clinical applications, providing flexibility for laboratories managing diverse diagnostic demands. Its multiplex capability enables the simultaneous detection of multiple targets, supporting more comprehensive and efficient testing workflows.
MultNAT® Multiplex Molecular POCT Instrument – Fast, Flexible, and Scalable
| Features: |
Benefits: |
- Multiplex testing capability
- Rapid time-to-result (~30–40 minutes)
- Quantitative testing capability
|
- Simultaneous detection of multiple pathogens or targets in a single run
- Faster clinical decision-making and improved patient management
- Enables monitoring of disease progression and treatment response
|
The EasyNAT® is a compact nucleic acid amplification and detection platform designed for rapid, accurate screening of infectious diseases at the point of care. Leveraging USTAR's isothermal amplification technology, EasyNAT® delivers laboratory-quality molecular testing without the complexity of traditional PCR systems.
Engineered for simplicity and accessibility, EasyNAT® enables healthcare providers to obtain fast, reliable results, supporting timely clinical decisions and improved patient management. With a growing CE-IVDR-aligned test menu, the platform provides flexibility to address evolving diagnostic needs across decentralised and laboratory settings.
EasyNAT®
| Features: |
Benefits: |
- Fully integrated sample-to-result workflow (single cartridge per sample)
- Rapid time-to-result (~30 minutes)
- High sensitivity and accuracy
|
- Minimal hands-on time and reduced contamination risk
- Enables immediate clinical decision-making
- Reliable detection for infectious disease screening
|
Through DKSH New Zealand, laboratories and healthcare providers benefit from our specialist Clinical Diagnostics team's local expertise, technical support, and seamless implementation of MultNAT® and EasyNAT® across clinical and decentralised environments. DKSH supports the distribution, implementation, and market expansion of USTAR technologies across Australia and New Zealand.
Discover how USTAR and DKSH New Zealand can support rapid testing for respiratory and infectious diseases.
